R. Rimmy Malhotra
R. Rimmy Malhotra's purchase track record
How the stock did after each of R. Rimmy Malhotra's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/26/2026 | GNSS | $2K | pending | pending | — |
| 6/24/2024 | HQI | $25K | +17.5% | +14.1% | +9.7% |
| 12/15/2023 | HQI | $97K | -21.0% | -20.8% | +15.1% |
| 12/27/2022 | HQI | $79K | +25.8% | +58.6% | +14.3% |
| 9/1/2021 | OPXS | $53K | +34.2% | +23.2% | -3.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
HireQuest (HQI) Lags Business Services Stocks This Year. A Yahoo article reports that HireQuest (HQI) is outperforming other business services stocks this year. The article highlights the company's strong performance relative to its peers. This suggests HireQuest may be a standout in the business services sector.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
OPXS Declines 24% Over Three Months, Analysts Discuss Next Steps. OPXS has fallen 24% over the past three months, prompting a Yahoo article that discusses whether to wait or act on the dip. The piece highlights the recent decline and examines potential next steps for the stock. It notes that the shares are trading near the $10.30 support level after the drop. The article provides context for investors monitoring the stock’s recent performance.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
INFU Shares Business Overview, Emphasizes Patient-First Strategy. INFU held a discussion outlining its business model and growth plans, highlighting a patient‑first approach to its services. The company emphasized expanding its product portfolio and improving customer engagement. The talk comes as the stock is near a key support level and shows moderate momentum. Analysts see upside potential, with a target range of $15‑$18.
Transaction History
| GNSS | ▲ Buy | Open Market | 1,000 | $2K | 8/26/2026 | View on chart |
| HQI | ▲ Buy | Grant | 1,036 | — | 8/12/2026 | View on chart |
| HQI | ▲ Buy | Grant | 4,000 | — | 8/12/2026 | View on chart |
| GNSS | ▲ Buy | Grant | 47,620 | $0 | 3/17/2026 | View on chart |
| HQI | ▲ Buy | Grant | 1,448 | — | 3/2/2026 | View on chart |
| HQI | ▲ Buy | Grant | 3,568 | — | 11/7/2025 | View on chart |
| OPXS | ▲ Buy | Grant | 4,000 | $67K | 11/4/2025 | View on chart |
| GNSS | ▲ Buy | Grant | 6,411 | $0 | 10/1/2025 | View on chart |
| OPXS | ▼ Sell | Open Market | 15,000 | $165K | 6/27/2025 | View on chart |
| HQI | ▲ Buy | Grant | 1,704 | — | 6/23/2025 | View on chart |
| HQI | ▲ Buy | Grant | 4,000 | — | 6/23/2025 | View on chart |
| OPXS | ▼ Sell | Open Market | 5,000 | $47K | 6/9/2025 | View on chart |
| GNSS | ▲ Buy | Grant | 38,136 | $0 | 3/17/2025 | View on chart |
| HQI | ▲ Buy | Grant | 1,287 | — | 2/13/2025 | View on chart |
| GNSS | ▲ Buy | Grant | 5,000 | — | 1/15/2025 | View on chart |
| HQI | ▲ Buy | Grant | 1,191 | — | 11/20/2024 | View on chart |
| OPXS | ▲ Buy | Grant | 7,600 | $62K | 11/5/2024 | View on chart |
| HQI | ▲ Buy | Grant | 400 | — | 9/30/2024 | View on chart |
| HQI | ▲ Buy | Grant | 1,278 | — | 8/13/2024 | View on chart |
| HQI | ▲ Buy | Grant | 8,000 | — | 6/27/2024 | View on chart |
| HQI | ▲ Buy | Open Market | 2,000 | $25K | 6/24/2024 | View on chart |
| HQI | ▲ Buy | Grant | 1,402 | — | 5/14/2024 | View on chart |
| HQI | ▲ Buy | Grant | 1,294 | — | 2/26/2024 | View on chart |
| HQI | ▲ Buy | Grant | 1,200 | — | 12/29/2023 | View on chart |
| HQI | ▲ Buy | Open Market | 2,000 | $33K | 12/15/2023 | View on chart |
| HQI | ▲ Buy | Open Market | 4,000 | $65K | 12/15/2023 | View on chart |
| HQI | ▲ Buy | Grant | 1,205 | — | 11/28/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 12,500 | $126K | 9/6/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 5,000 | $51K | 9/5/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 12,500 | $128K | 9/1/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 10,000 | $104K | 8/31/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 5,000 | $51K | 8/30/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 10,000 | $103K | 8/29/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 5,000 | $52K | 8/28/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 10,000 | $102K | 8/25/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 10,000 | $108K | 8/23/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 19,856 | $212K | 8/18/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 15,560 | $165K | 8/17/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 10,000 | $107K | 8/16/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 15,000 | $160K | 8/15/2023 | View on chart |
| HQI | ▲ Buy | Grant | 916 | — | 8/15/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 5,000 | $54K | 8/14/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 20,000 | $174K | 6/8/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 7,158 | $64K | 6/7/2023 | View on chart |
| INFU | ▼ Sell | Open Market | 5,000 | $45K | 6/6/2023 | View on chart |
| HQI | ▲ Buy | Grant | 979 | — | 12/30/2022 | View on chart |
| HQI | ▲ Buy | Open Market | 809 | $13K | 12/28/2022 | View on chart |
| HQI | ▲ Buy | Open Market | 1,000 | $16K | 12/28/2022 | View on chart |
| HQI | ▲ Buy | Open Market | 2,895 | $47K | 12/27/2022 | View on chart |
| HQI | ▲ Buy | Open Market | 191 | $3K | 12/27/2022 | View on chart |
| OPXS | ▼ Sell | Other | 21,624 | $57K | 9/20/2022 | View on chart |
| OPXS | ▼ Sell | Other | 88,858 | $235K | 9/20/2022 | View on chart |
| HQI | ▲ Buy | Grant | 5,216 | — | 7/11/2022 | View on chart |
| HQI | ▲ Buy | Grant | 948 | — | 4/20/2022 | View on chart |
| HQI | ▲ Buy | Grant | 996 | — | 1/28/2022 | View on chart |
| HQI | ▲ Buy | Grant | 875 | — | 11/8/2021 | View on chart |
| OPXS | ▲ Buy | Open Market | 10,000 | $17K | 9/8/2021 | View on chart |
| OPXS | ▲ Buy | Open Market | 8,846 | $15K | 9/7/2021 | View on chart |
| OPXS | ▲ Buy | Open Market | 4,991 | $8K | 9/3/2021 | View on chart |
| OPXS | ▲ Buy | Open Market | 5,810 | $9K | 9/1/2021 | View on chart |
| OPXS | ▲ Buy | Open Market | 2,500 | $4K | 9/1/2021 | View on chart |
| HQI | ▲ Buy | Grant | 937 | — | 8/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Genasys Secures $1.5M in New Orders and National Guard Contract
Genasys reported receiving $1.5 million in new orders for its voice broadcast and mass notification systems. Additionally, the company secured a follow-on order from the National Guard for LRAD devices, bringing total orders to $8.5 million. Butte County in California also selected Genasys Protect to improve its wildfire preparedness and emergency management capabilities.
Genasys Secures $1.5M in New Orders and National Guard Contract. Genasys reported receiving $1.5 million in new orders for its voice broadcast and mass notification systems. Additionally, the company secured a follow-on order from the National Guard for LRAD devices, bringing total orders to $8.5 million. Butte County in California also selected Genasys Protect to improve its wildfire preparedness and emergency management capabilities.